Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Whitehall efficacy ad claims for Dimetapp Extentabs substantiated, NAD concludes.

This article was originally published in The Tan Sheet

Executive Summary

WHITEHALL-ROBINS' DIMETAPP EXTENTABS AD CLAIMS SUBSTANTIATED, the National Advertising Division of the Council of Better Business Bureaus concluded in a NAD Case Report published Aug. 7. The print and television ad claims reviewed were: "An allergy study showed [Dimetapp's] antihistamine is even more effective than Seldane, a leading prescription. Ask your doctor. Dimetapp relieved my sneezing, runny nose, itchy eyes and it didn't make me as drowsy as Benadryl" and "More Effective Than Seldane." The ads were created by Young & Rubicam, New York.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel